Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis
Key facts
- Phase
- Phase 1
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 42 and 75 years old?
Source: NCT06937528, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Jordan
- Trial code
- NCT06937528
- Record updated
- 22 April 2025
- Original description
Extracellular vesicles (EV) will be injected in patients diagnosed with Knee osteoarthrosisRead full original descriptionShow less
Knee Osteoarthrosis (KOA) in Jordanian Patients: a Phase I Dose-finding Study Using Extracellular Vesicles (EV) for Advanced Stage III and IV KOA
Extracellular vesicles (EV) will be injected in patients diagnosed with Knee osteoarthrosis
Inclusion: Severe KOA stage III or IV by Laurance \& Kellgren staging as judged by Posterioranterior (PA) Xray of the knee joint; Willing to participate by signing the informed consent.
Exclusion: Oral anticoagulants or heparin therapy; Heart failure or arrhythmia; Uncontrolled Diabetes Mellitus; Evidence of Infectious Diseases; Active infection; Malignancy; Sublaxation beyond 20 degrees of the bones of the knee joint; Body Mass Index > 35; Pregnancy; Anemia less than 11g/dl or thrombocytopenia less than 100,000 or leucopenia less than 3000; Unreliable patients; Non-resident in Jordan.